NEW YORK (GenomeWeb) – A new study has taken the first steps in assessing whether commercially available multiplex panels can be used to deduce the cause of prosthetic joint infection, or PJI.
Published last month in the Journal of Clinical Microbiology, the study evaluated the performance of the FilmArray Blood Culture ID panel from BioMérieux subsidiary BioFire Diagnostics.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
